ENT — Updates Since 2020

Guideline & practice changes since 2020

  • Mepolizumab (PBS-listed April 2023) is now a second biologic option, alongside dupilumab, for chronic rhinosinusitis with nasal polyposis. See Rhinitis, Sinusitis & Rhinosinusitis and Nasal Polyps.
  • Sudden sensorineural hearing loss is now framed as a time-critical otologic emergency — urgent ENT/ED referral and immediate high-dose corticosteroids, without waiting for an audiogram. See Loss of Hearing (Acute & Chronic).
  • SSNHL management now extends beyond the acute window. Patients presenting more than 30 days after onset should still get urgent ENT referral to assess candidacy for intra-tympanic corticosteroid injection as salvage treatment (a meta-analysis found a mean +13.3dB improvement); hyperbaric oxygen therapy is a reasonable adjunct started early for acute SSNHL (Cochrane review: NNT 5 for improvement) but shows no benefit once loss is chronic (≥6 months); a separate Cochrane review found no added benefit from antiviral drugs. See Loss of Hearing (Acute & Chronic).
  • Adding a topical corticosteroid to topical antibiotics for chronic suppurative otitis media has no proven added benefit — a 2025 Cochrane review of 19 studies found no difference in resolution of discharge at 1–2 weeks, with low-certainty evidence that antibiotic alone may in fact do better for some drug classes; quinolone drops (ciprofloxacin/ofloxacin) remain preferred over aminoglycoside/polymyxin drops, which risk ototoxicity through a perforated eardrum. See Chronic Suppurative Otitis Media.
  • Medical treatment for otitis media with effusion (“glue ear”) still lacks durable benefit — 2023 Cochrane reviews found antibiotics only “might slightly reduce” effusion at 3 months, oral steroids show unclear/modest benefit at 6–12 months against harms like bone loss, and nasal steroids show even less evidence of benefit — reinforcing watchful waiting as the default for most children. See Otitis Media with Effusion.
  • Button-battery and disc-magnet ear/nose foreign bodies now carry an explicit urgent-referral safety warning (rapid tissue damage risk).
  • The Modified Centor Criteria has demonstrated antibiotic-stewardship benefit (77.7% vs 85.5% prescribing).
  • “All adult neck masses are malignant until proven otherwise” — reinforced with documented 180-day-referral and 3× mortality associations, plus rising HPV-driven oropharyngeal SCC. See Neck Lumps.
  • Parotitis management ladder expanded (aetiology, red-flag referral, imaging comparison), plus a new postoperative-parotidectomy section (Frey syndrome, sialocele, first-bite syndrome). See Parotitis.
  • Paediatric OSA evidence (polysomnography, oximetry screening, adenotonsillectomy effectiveness) added. See Snoring.
  • Laryngeal cancer gained a survivorship/surveillance section. See Laryngeal Cancer.
  • Sudden sensorineural hearing loss no longer needs a routine laboratory work-up — a 2024 AJGP review notes current American Academy of Otolaryngology–Head and Neck Surgery guidance recommends against routine labs for idiopathic SSNHL; testing is now targeted to specific clinical suspicion only. See Loss of Hearing (Acute & Chronic).
  • New “Peritonsillar abscess (quinsy)” section on the sore-throat page — point-of-care ultrasound is now recommended first-line imaging (contrast CT as gold standard where POCUS isn’t available), plus a Cochrane-sourced NNT for antibiotics in sore throat generally (3.7 in strep-positive patients, 14.4 if unswabbed). See Sore Throat.

New pages added

  • Dental & Oral Emergencies (2026-09-01) — odontogenic infection: severity classification (localised / spreading / spreading with severe or systemic features including Ludwig angina), antibiotic regimens for each tier, red flags for airway compromise, and infection after dentoalveolar surgery. Written against 5 eTG odontogenic-infection topics. Currently covers infection only — dental trauma and dry socket are not yet written.
  • Nasal Foreign Body (2026-09-01) — where objects lodge, the positive-pressure (“parent’s kiss”) technique, microsuction/forceps removal, why irrigation isn’t recommended, and the button-battery same-day emergency. Scoped to nasal foreign body only — aural foreign body was already comprehensively covered on Blocked Ear, so this page cross-links there rather than duplicating it.
  • Auricular Haematoma (2026-09-01) — time- critical drainage (needle aspiration under 6 hours/2 cm vs incision and drainage beyond that), pressure-dressing techniques that actually prevent recurrence, otolaryngology referral’s effect on reaccumulation rates, and ear-protection prevention data.
  • Tinnitus
  • Anosmia & Smell Loss